Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice.

Autor: Macor, P1, Secco, E1, Mezzaroba, N1, Zorzet, S1, Durigutto, P1, Gaiotto, T2, De Maso, L1, Biffi, S3, Garrovo, C3, Capolla, S1, Tripodo, C4, Gattei, V5, Marzari, R1, Tedesco, F6, Sblattero, D7
Zdroj: Leukemia (08876924). Feb2015, Vol. 29 Issue 2, p406-414. 9p.
Databáze: Academic Search Ultimate